What compounding means
The two paths are not the same.
Names matter.
Ask who made the drug and which rule applies.
Keep each answer short.
Save the full name.
Compounding is when a pharmacist, a doctor, or a larger FDA-registered plant (an outsourcing facility) makes a medicine to order instead of a finished FDA-approved product.
Compounded medicines carry no FDA approval, and nobody at FDA checks their safety, effectiveness, or quality before they go on sale.
That lack of approval is true even when the pharmacy is licensed and careful.
Keep the check plain
Who made it?
Get the full name.
What is in it?
Use the exact drug name.
Why this form?
Ask what need the change meets.
Which path fits?
Match the answer to the pharmacy or facility.
Who takes the next call?
Keep a real contact close.
The two kinds of compounder
Patient-specific pharmacy
As of September 2026, the first kind is an ordinary pharmacy, or a doctor, preparing a medicine for a single, named patient who holds a valid prescription. The label 503A points to the section of federal drug law that governs it.
Outsourcing facility
As of September 2026, the second kind is a bigger operation producing sterile (germ-free) medicine in batches, frequently supplying clinics and hospitals. Known as a 503B outsourcing facility, it can work without a prescription that names you.
The quality rules differ
As of September 2026, a 503B plant must follow the same quality rules as a drug factory, and FDA inspects it, visiting more often where it sees more danger.
A regular 503A pharmacy does not have to follow those factory rules.
It still answers to its state pharmacy board, so ask the pharmacy how it checks each batch for strength and cleanliness.